Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS
Endocrinologist
M.B.B.S, F.C.P.S. (Medicine), F.C.P.S. (Endocrinology)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, MRCP (UK), MRCGP (UK), MRCPS (Glasgow), CCT (UK)
Internal Medicine Specialist
MBBS, MRCP (UK), MRCGP (UK), MRCPS (Glasgow), CCT (UK)
Internal Medicine Specialist
MBBS, MCPS (Family Medicine), CEFM
Internal Medicine Specialist
B.Sc, M.B.B.S., Certification in Diabetes , F.C.P.S (Medicine), MACP (USA), Fellow of Gastroenterology, MRCP 1 & 2 UK, MACG(USA)
Internal Medicine Specialist
B.Sc, M.B.B.S., Certification in Diabetes , F.C.P.S (Medicine), MACP (USA), Fellow of Gastroenterology, MRCP 1 & 2 UK, MACG(USA)
Internal Medicine Specialist
M.B.B.S, F.C.P.S. ( MEDICINE )
Consultant Physician
M.B.B.S, F.C.P.S. (Medicine), Postgraduate Diploma in Diabetes (UK), MRCP (Endocrinology and Dibetes)
Consultant Physician
M.B.B.S, F.C.P.S. (Medicine), Postgraduate Diploma in Diabetes (UK), MRCP (Endocrinology and Dibetes)
Internal Medicine Specialist
M.B.B.S., F.C.P.S (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures